A Clinical Pharmacology Trial of Brexpiprazole Long Acting Injectable (LAI) Administered as a Single Dose in Patients With Schizophrenia
Clinical trial NCT05119894 · WITHDRAWN
Trial details
- NCT number
- NCT05119894
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-22
- Primary completion
- 2021-12-06
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.